About this journal

Aims and scope

Neuropsychiatric Disease and Treatment is an international, peer reviewed, open access journal publishing on all aspects of neuropsychiatric and neurological disorders. The journal is characterized by the rapid reporting of new and emerging clinical or pre-clinical studies, pharmacology and therapeutic strategies to overcome a wide range of conditions as well as the diagnosis, prognosis, epidemiology and genetic associations of these diseases.

Topics covered in this journal include:

  • Biological basis and clinical treatment of Neuropsychiatric conditions such as Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorders, Anxiety and Depressive Disorders, Bipolar Disorders and Schizophrenia
  • Biological basis and clinical treatment of Neurological conditions such as Dementia, Parkinson's Disease, Epilepsy, Multiple Sclerosis, Migraines, Strokes
  • Research on the normal brain which gives insight into potential dysfunction, disease or the mechanisms of treatments

The journal welcomes submitted papers covering original research, reviews and evaluations, guidelines, expert opinion and commentary, and extended reports.

Case reports/series submitted to Neuropsychiatric Disease and Treatment will be diverted to the Neuropsychiatric Disease and Treatment section of the International Medical Case Reports Journal. (Journal metric data for this journal can be accessed here).

When considering submission of a paper utilizing publicly available data, authors should ensure that such studies add significantly to the body of knowledge and that they are validated using the authors' own data through replication in an original sample.

All meta-analyses require a pre-submission check prior to submitting to Neuropsychiatric Disease and Treatment. Please complete the pre-submission check form here.

Journal metrics

Usage

  • 679K annual downloads/views

Citation metrics

  • 2.5 (2023) Impact Factor
  • Q2 Impact Factor Best Quartile
  • 3.0 (2023) 5 year IF
  • 5.5 (2023) CiteScore (Scopus)
  • Q2 CiteScore Best Quartile
  • 0.975 (2023) SNIP
  • 0.849 (2023) SJR

Editorial board

Editor-in-Chief:

Dr Roger Pinder, Pharma, Independent Pharma Consultant, United Kingdom

Associate Editors-in-Chief:

Dr Jun Chen, Clinical Research Center, Shanghai Mental Health Center, China Mainland (PRC)

Dr Taro Kishi, Psychiatry, Fujita Health University School of Medicine, Japan

Dr Rakesh Kumar, Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN, USA 

Dr Yuping Ning, Department of Psychiatry, Mental Health Institute of the Second Xiangya Hospital, Central South University, China Mainland (PRC)

Editorial Board:

Hojjat Adeli is an Academy Professor at The Ohio State University. He is the recipient of eight Honorary Doctorates and elected into five European Academies. He is the co-author of 16 ground-breaking books including: Automated EEG-based Diagnosis of Neurological Disorders - Inventing the Future of Neurology (CRC Press 2010), USA

Dr Kristian Barlinn, Neurology, University Hospital Carl Gustav Carus Dresden, Germany

Professor Marlene Oscar Berman, Psychiatry, Neurology, Anatomy and Neurobiology, Boston University School of Medicine, Boston, Massachusetts, USA, Dr. Berman also is a Research Scientist at the Department of Veterans Affairs Healthcare facility in Boston.

Prof. Dr. Francesca Bisulli, Department of Biomedical and Neuromotor Sciences, University of Bologna, Italy

Professor Tindara Capri, Department of Life and Health Sciences, Link Campus University, Rome, Italy

Professor Sau Man Sandra Chan, Department of Psychiatry, The Chinese University of Hong Kong, Hong Kong

Prof. Dr. Lin Chen, Department of Neurosurgery, Tsinghua University Yuquan Hospital, China Mainland (PRC)

Professor Wai Tong Chien, The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong

Dr Francesco Craig, Child and Adolescent Neuropsychiatry, Department of Cultures, Education and Society, University of Calabria, Italy, Italy

Alessandro Cuomo, MD-PhD, Assistant Professor in Psychiatry, Division of Psychiatry, Department of Molecular Medicine, University of Siena School of Medicine, Italy

Professor Anthony S David, Institute of Mental Health, University College London, United Kingdom

Professor Valsamma Eapen, Department and Faculty Head, School of Psychiatry, University of New South Wales, Australia

Professor Andrea Fagiolini, Molecular Medicine, University of Siena, Italy

Dr Mike Isaac, Psychiatry, South London & Maudsley NHS FT and University of London, United Kingdom

Prof. Dr. Andrey Iznak, Neurophysiology, Mental Health Research Centre, Russia

Professor Sidney Kennedy, Department of Psychiatry, University Health Network, University of Toronto, Canada

Dr Firas H Kobeissy, Department of Neuroscience, Morehouse School of Medicine, Atlanta, Georgia, USA

Professor Reinhard Michael Krausz, Psychiatry, The University of British Columbia, Canada

Dr John Markowitz, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, United States

Professor Peter Martin, Psychiatry and Pharmacology, Vanderbilt Psychiatric Hospital, United States

Professor Julien Mendlewicz, Department of Psychiatry, Free University of Brussels, Belgium

Prof. Dr. Shinichi Mitsui, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Japan

Dr Zoran Pavlovic, Heruka Lifescience & Health Innovations, Serbia

Prof. Steven Potkin, Department of Psychiatry, University of California, Irvine, United States

Prof. Dr. Norman Sartorius, President, Association for the Improvement of Mental Health Programmes (AMH), Geneva, Switzerland

Prof. Dr. Alessandro Serretti, Department of Biomedical and NeuroMotor Sciences, Bologna University, Italy

Dr Timo Siepmann, Professor, PD Dr. med. habil, FAHA - Attending physician and director of the Telestroke Network Eastern Saxony (SOS TeleNET). He is also scientific director of the Master’s Program in Clinical Research at Dresden International University and Site Director of Dresden Site at Principles and Practice of Clinical Research, Harvard T.H. Chan School of Public Health. Professor Siepmann is an International Fellow of the American Heart Association, Germany

Dr Edoardo Spina, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy

Dr Eduard Vieta, Hospital Clinic, Institute of Neuroscience, University of Barcelona, Spain

Dr Ng Beng Yeong, Consultant Psychiatrist, Mount Elizabeth Medical Centre, Singapore

Professor Nathan Zasler, Virginia Commonwealth University and University of Virginia, Charlottesville, Virginia, United States

Abstracting and indexing

Neuropsychiatric Disease and Treatment is indexed/tracked/covered by the following services:

American Psychological Association's 'PsycINFO' database

Current Contents®/Clinical Medicine

Directory of Open Access Journals (DOAJ)

EMBASE (Elsevier)

ICAAP

Index Copernicus

Journal Citation Reports/Science Edition

Pubmed (NLM)

PubMed Central Selective Deposit Medicine & Health (NLM)

Science Citation Index Expanded (Clarivate Analytics)

Scopus (Elsevier)

Open access

Neuropsychiatric Disease and Treatment is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.

Use our APC finder to calculate your article publishing charge

News, offers and calls for papers

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors